Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T14:51:48.123Z.
Calculation as of: 2026-10-06T14:51:48.123Z.
Quote observation: 2026-10-06T14:50:15.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4f3bc52aaee10dc4864d073eee8720ed85d0d11e7a3d16422bde167dd05b99a5
EARNINGS YIELD
N/A
Market Cap
$90.97M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$88.21M
Earnings Yield
0.87%
TTM Avg
3.26%
3Y Avg
3.22%
5Y Avg
1.83%
Market Cap
$95.88M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| electroCore, Inc. (ECOR) | $92.14M | N/A | N/A | N/A | N/A |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $90.97M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 0.87% | 3.26% | 3.22% | 1.83% |
| Biomea Fusion, Inc. (BMEA)vs › | $91.10M | N/A | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $89.76M | N/A | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $95.55M | N/A | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $87.90M | N/A | N/A | N/A | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $95.88M | N/A | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 3.41% | 2.77% | 2.77% | 8.10% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $86.05M | N/A | 39.78% | 39.78% | 39.78% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute